[go: up one dir, main page]

CN105669542A - Method for synthesizing pyridine primary amides by direct catalytic oxidation process - Google Patents

Method for synthesizing pyridine primary amides by direct catalytic oxidation process Download PDF

Info

Publication number
CN105669542A
CN105669542A CN201610131789.3A CN201610131789A CN105669542A CN 105669542 A CN105669542 A CN 105669542A CN 201610131789 A CN201610131789 A CN 201610131789A CN 105669542 A CN105669542 A CN 105669542A
Authority
CN
China
Prior art keywords
silver
acid
sodium
pyridine
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610131789.3A
Other languages
Chinese (zh)
Inventor
韩维
姚利芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Normal University
Original Assignee
Nanjing Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Normal University filed Critical Nanjing Normal University
Priority to CN201610131789.3A priority Critical patent/CN105669542A/en
Publication of CN105669542A publication Critical patent/CN105669542A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

本发明公开了一种直接催化氧化法合成吡啶伯酰胺化合物的方法,在酸或碱的作用下,以甲酰胺为羰基源和氮源,加入促进剂水和氧化剂,在银和/或铁催化剂的作用下,催化氧化吡啶或其衍生物的碳-氢键直接制备得到吡啶伯酰胺化合物。本发明的制备吡啶伯酰胺化合物的方法,通过活化双碳-氢键,具有理想的原子经济性和产生废物少的优点,底物来源广泛、稳定且价格低廉。在优化的反应条件之下,目标产品分离收率高达98%。 The invention discloses a method for synthesizing pyridine primary amide compounds by direct catalytic oxidation method. Under the action of acid or alkali, formamide is used as carbonyl source and nitrogen source, and accelerator water and oxidant are added, and silver and/or iron catalyst Under the action of catalysis, the carbon-hydrogen bond of pyridine or its derivatives can be directly prepared to obtain pyridine primary amide compound. The method for preparing pyridine primary amide compound of the present invention has the advantages of ideal atom economy and less waste generation by activating double carbon-hydrogen bonds, and the substrate source is wide, stable and low in price. Under optimized reaction conditions, the separation yield of the target product is as high as 98%.

Description

一种直接催化氧化法合成吡啶伯酰胺化合物的方法A kind of method of synthesizing pyridine primary amide compound by direct catalytic oxidation method

技术领域technical field

本发明涉及一种吡啶伯酰胺类化合物的合成方法,特别是涉及一种直接利用甲酰胺为氨甲酰源,催化氧化吡啶类化合物的碳-氢键来合成吡啶伯酰胺类化合物的方法。The invention relates to a method for synthesizing primary pyridine amides, in particular to a method for directly using formamide as a carboxamide source to catalyze oxidation of the carbon-hydrogen bond of pyridines to synthesize pyridine primary amides.

背景技术Background technique

吡啶伯酰胺类化合物是一类具有特优生理活性的化合物,其基本结构单元存在于大量的天然产物、医药和除草剂中,并广泛应用于生物、医药和材料等领域。合成此类物质的传统方法是吡啶酸或吡啶酰氯与氨的反应;近年来催化合成方法具有效率高和适用范围广等优势引起了广泛关注。Pyridine primary amides are a class of compounds with excellent physiological activity. Their basic structural units exist in a large number of natural products, medicines and herbicides, and are widely used in the fields of biology, medicine and materials. The traditional method of synthesizing such substances is the reaction of pyridine acid or pyridine acid chloride with ammonia; in recent years, the catalytic synthesis method has attracted widespread attention due to its advantages of high efficiency and wide application range.

Beller课题组首次报道了钯催化的氨甲酰化溴吡啶和氯吡啶反应,来制备吡啶伯酰胺,所用的羰基源为一氧化碳,氮源为氨气,该反应成功的关键在于筛选出了一个高效的膦配体cataCXiumA(Xiao-FengWu,HelfriedNeumann,MatthiasBeller,Chem.Eur.J.2010,16,9750-9753)。考虑到配体cataCXiumA复杂和难以合成,该小组进一步研究使用更为廉价的配体,发现商业化的膦配体dppf可以取得等同的催化效果(Xiao-FengWu,HelfriedNeumann,MatthiasBeller,Chem.AsianJ.2010,5,2168-2172)。紧接着,该小组又开发了一种新的膦配体Pyr-DalPhos,并对溴吡啶的氨甲酰化取得了较好的催化效果(PamelaG.Alsabeh,MarkStradiotto,HelfriedNeumann,MatthiasBeller,Adv.Synth.Catal.2012,354,3065–3070)。苯酚是一类廉价易得的反应物,但酚羟基因与芳环共轭,而难于离去。该小组通过苯酚与全氟丁基磺酰氟原位形成酯来参与Pd-DPEphos催化的氨甲酰化反应来制备吡啶伯酰胺(Xiao-FengWu,HelfriedNeumann,MatthiasBeller,Chem.Eur.J.2012,18,419–422)。虽然这些方法合成效率高,所用的羰基源和氮源廉价,但是,它们有毒、易燃并存在安全等问题。因此,使用更加安全和无毒的羰基化和胺化试剂来合成吡啶伯酰胺具有重要的研究价值和应用前景。The Beller research group reported for the first time the palladium-catalyzed carbamylation reaction of bromopyridine and chloropyridine to prepare pyridine primary amides. The carbonyl source used was carbon monoxide and the nitrogen source was ammonia gas. The key to the success of this reaction was the screening of a highly efficient The phosphine ligand cataCXiumA (Xiao-Feng Wu, Helfried Neumann, Matthias Beller, Chem. Eur. J. 2010, 16, 9750-9753). Considering that the ligand cataCXiumA is complex and difficult to synthesize, the group further studied the use of cheaper ligands and found that the commercial phosphine ligand dppf can achieve the same catalytic effect (Xiao-FengWu, Helfried Neumann, MatthiasBeller, Chem.AsianJ.2010 , 5, 2168-2172). Immediately afterwards, the group developed a new phosphine ligand, Pyr-DalPhos, and achieved a better catalytic effect on the carbamylation of bromopyridine (PamelaG.Alsabeh, MarkStradiotto, HelfriedNeumann, MatthiasBeller, Adv.Synth. Catal. 2012, 354, 3065–3070). Phenol is a cheap and easy-to-obtain reactant, but it is difficult to leave the phenolic hydroxyl group due to its conjugation with the aromatic ring. The group participated in the carbamylation reaction catalyzed by Pd-DPEphos to prepare pyridine primary amides by in situ ester formation of phenol and perfluorobutylsulfonyl fluoride (Xiao-Feng Wu, Helfried Neumann, Matthias Beller, Chem. Eur. J. 2012, 18, 419–422). Although these methods have high synthesis efficiency and the carbonyl and nitrogen sources used are cheap, they are toxic, flammable and have safety problems. Therefore, the use of safer and non-toxic carbonylation and amination reagents to synthesize pyridine primary amides has important research value and application prospects.

最近,Skrydstrup小组利用非原位形成一氧化碳作为羰基源和氨基甲酸铵作为氮源,在钯和膦配体存在下,有效地氨甲酰化3-溴吡啶和对甲苯磺酸吡啶酯,制得对应的吡啶伯酰胺(DennisU.Nielsen,RolfH.Taaning,AndersT.Lindhardt,ThomasM.TroelsSkrydstrup,Org.Lett.2011,13,4454–4457)。以上所有方法都存在着使用昂贵、有毒和不稳定的膦配体的问题,增加了生产成本和产物分离的难度,同时,反应物都需要用到官能团化的吡啶,反应结束后这些官能团都成为离去基而形成废物。最为理想的方法是直接利用吡啶的碳-氢键进行氨甲酰化反应,节省预官能团化吡啶步骤,从而产生的废物少,原料利用率高,节约资源和能源。Recently, the Skrydstrup group utilized ex situ formation of carbon monoxide as the carbonyl source and ammonium carbamate as the nitrogen source to efficiently carbamylate 3-bromopyridine and pyridinium p-toluenesulfonate in the presence of palladium and phosphine ligands to prepare Corresponding pyridine primary amides (DennisU.Nielsen, RolfH.Taaning, AndersT.Lindhardt, ThomasM. Troels Skrydstrup, Org. Lett. 2011, 13, 4454–4457). All of the above methods have the problem of using expensive, toxic and unstable phosphine ligands, which increases the production cost and the difficulty of product separation. At the same time, the reactants all need to use functionalized pyridine. After the reaction, these functional groups become Leaving bases to form waste. The most ideal method is to directly use the carbon-hydrogen bond of pyridine to carry out the carbamylation reaction, saving the step of pre-functionalization of pyridine, resulting in less waste, high utilization of raw materials, and resource and energy saving.

然而,截至目前,一种直接通过活化吡啶碳-氢进行氨甲酰化反应来合成高附加值产品吡啶伯酰胺类化合物的方法尚未见报道。However, up to now, a method for directly synthesizing high value-added primary pyridine amides by activating pyridine carbon-hydrogen for carbamylation has not been reported.

发明内容Contents of the invention

本发明的主要目的在于,克服现有的预官能团化的吡啶类化合物催化氨甲酰化合成吡啶伯酰胺类化合物方法存在的缺陷,而提供一种新的合成吡啶伯酰胺化合物的方法,在银和/或铁催化剂作用下,加入甲酰胺作为氨甲酰试剂,水作为促进剂,空气或氧气气氛下直接氧化吡啶类化合物的碳-氢键合成吡啶伯酰胺类化合物,该方法具有底物来源广泛、稳定和廉价,催化剂廉价易得、反应选择性高、产生废物少、适用范围广和目标产物收率高的优势。The main purpose of the present invention is to overcome the defects in the existing pre-functionalized pyridine compound catalyzed carbamylation method to synthesize pyridine primary amide compounds, and provide a new method for synthesizing pyridine primary amide compounds. And/or under the action of an iron catalyst, formamide is added as a carboxamide reagent, water is used as a promoter, and the carbon-hydrogen bond of a pyridine compound is directly oxidized under an air or oxygen atmosphere to synthesize a pyridine primary amide compound. This method has a substrate source Extensive, stable and cheap, with cheap and easy-to-obtain catalysts, high reaction selectivity, less waste generation, wide application range and high yield of target products.

本发明为实现上述目的及解决其技术问题,采用以下技术方案:The present invention adopts the following technical solutions in order to achieve the above object and solve its technical problems:

一种直接催化氧化法合成吡啶伯酰胺化合物的方法,其特征在于,在空气或氧气气氛下,加入氧化剂、促进剂水以及酸或碱,以甲酰胺为氨甲酰化试剂,在银催化剂和/或铁催化剂作用下,催化氧化吡啶或其衍生物的碳-氢键直接制备得到吡啶伯酰胺化合物,反应通式表示如下:A method for synthesizing pyridine primary amide compounds by direct catalytic oxidation method is characterized in that, under air or oxygen atmosphere, add oxidizing agent, promotor water and acid or alkali, take formamide as carbamylation reagent, in silver catalyst and /or under the action of an iron catalyst, the carbon-hydrogen bond of catalyzed oxidation of pyridine or its derivatives is directly prepared to obtain the pyridine primary amide compound, and the general reaction formula is as follows:

式中R1~R4任意选自氢,C1~C12的烷基、烯基或炔基,C1~C12的烷氧基,C1~C12的氟取代烷基,C3~C12的环烷基,芳基、芳氧基或芳胺基,杂芳基、杂芳氧基或杂芳胺基,C1~C12烷基取代的氨基,C1~C12巯基,氟,羟基,C1~C12烷基羰基,C1~C12烷氧基羰基,芳基羰基,羧基,C1~C12烷酰氧基,氰基,C1~C12烷磺酰基,磺酸基,磺酸酯基,磷酸酯基或硝基;In the formula , R1 - R4 are randomly selected from hydrogen, C1-C12 alkyl, alkenyl or alkynyl, C1-C12 alkoxy, C1-C12 fluorine-substituted alkyl, C3-C12 cycloalkyl, Aryl, aryloxy or arylamino, heteroaryl, heteroaryloxy or heteroarylamino, C1~C12 alkyl substituted amino, C1~C12 mercapto, fluorine, hydroxyl, C1~C12 alkylcarbonyl, C1~C12 alkoxycarbonyl, arylcarbonyl, carboxyl, C1~C12 alkanoyloxy, cyano, C1~C12 alkanesulfonyl, sulfonic acid, sulfonate, phosphate or nitro;

优选地,所述的杂芳基为含一个或多个N、O或S的五~十四元环的杂芳基。Preferably, the heteroaryl group is a five- to fourteen-membered heteroaryl group containing one or more N, O or S.

上述方法中,所述的酸为三氟甲酸、三氟乙酸、甲酸、乙酸、特戊酸、2-硝基苯甲酸、对甲苯磺酸或三氟甲磺酸。In the above method, the acid is trifluoroformic acid, trifluoroacetic acid, formic acid, acetic acid, pivalic acid, 2-nitrobenzoic acid, p-toluenesulfonic acid or trifluoromethanesulfonic acid.

上述方法中,所述的碱为无机碱或有机碱。无机碱包括但不限于磷酸钾、磷酸钠、氟化钠、氟化钾、氟化铯、碳酸锂、碳酸钠、碳酸钾、碳酸铯、甲醇钠、乙酸钠、乙酸钾、乙酸铯、乙醇钠、叔丁醇锂、氢氧化锂、丙酸钠、丙酸钾、丁酸钠、丁酸钾、苯甲酸钠、特戊酸钠、特戊酸钾;有机碱包括但不限于四丁基氟化铵、三乙胺、二异丙基乙胺、三丁胺、1,4-二氮杂二环[2.2.2]辛烷、1,8-二氮杂二环[5.4.0]十一碳-7-烯或1,5-二氮杂二环[4.3.0]壬-5-烯。且上述各碱可以组合使用。最优选的碱为乙酸钠。In the above method, the base is an inorganic base or an organic base. Inorganic bases include but are not limited to potassium phosphate, sodium phosphate, sodium fluoride, potassium fluoride, cesium fluoride, lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, sodium methoxide, sodium acetate, potassium acetate, cesium acetate, sodium ethoxide , lithium tert-butoxide, lithium hydroxide, sodium propionate, potassium propionate, sodium butyrate, potassium butyrate, sodium benzoate, sodium pivalate, potassium pivalate; organic bases include but not limited to tetrabutyl fluoride Ammonium, triethylamine, diisopropylethylamine, tributylamine, 1,4-diazabicyclo[2.2.2]octane, 1,8-diazabicyclo[5.4.0]undeca Carbo-7-ene or 1,5-diazabicyclo[4.3.0]non-5-ene. And each of the above-mentioned bases may be used in combination. The most preferred base is sodium acetate.

上述方法中,所述的催化剂为银催化剂或铁催化剂,或两者以任意比例组成的混合物。所述的银催化剂包括但不限于硝酸银、醋酸银、三氟乙酸银、硫酸银、氟硼酸银、乳酸银、磷酸银、硫化银、氟化银、氯化银、碘化银、溴化银、碳酸银、对甲苯磺酸银、三氟甲磺酸银、苯甲酸银或甲磺酸银;所述的铁催化剂包括但不限于铁粉、三氟甲磺酸亚铁、三氟甲磺酸铁、氯化亚铁、乙酰丙酮铁、铁氰化亚铁、铁氰化铁、醋酸亚铁、硫酸亚铁、硫酸亚铁铵、草酸亚铁、草酸铁、氟化亚铁、氟化铁、溴化亚铁、溴化铁、碘化亚铁、三氯化铁、氧化铁、四氧化三铁。最优选的催化剂为硝酸银。In the above method, the catalyst is a silver catalyst or an iron catalyst, or a mixture of the two in any proportion. The silver catalysts include but are not limited to silver nitrate, silver acetate, silver trifluoroacetate, silver sulfate, silver fluoroborate, silver lactate, silver phosphate, silver sulfide, silver fluoride, silver chloride, silver iodide, silver bromide, Silver carbonate, silver p-toluenesulfonate, silver trifluoromethanesulfonate, silver benzoate or silver methanesulfonate; the iron catalyst includes but not limited to iron powder, ferrous trifluoromethanesulfonate, trifluoromethanesulfonic acid Iron, ferrous chloride, ferric acetylacetonate, ferrous ferricyanide, ferric ferricyanide, ferrous acetate, ferrous sulfate, ammonium ferrous sulfate, ferrous oxalate, ferric oxalate, ferrous fluoride, ferric fluoride , ferrous bromide, ferric bromide, ferrous iodide, ferric chloride, ferric oxide, ferric oxide. The most preferred catalyst is silver nitrate.

上述方法中,所述的氧化剂包括但不限于过硫酸铵、过硫酸钾、过硫酸钠、过氧硫酸氢钾复合盐、二叔丁基过氧化物、过氧化二异丙苯。最优选的氧化剂为过硫酸钾。In the above method, the oxidizing agent includes but not limited to ammonium persulfate, potassium persulfate, sodium persulfate, potassium hydrogen peroxosulfate complex salt, di-tert-butyl peroxide, and dicumyl peroxide. The most preferred oxidizing agent is potassium persulfate.

上述方法中,所述的羰基源和氮源为甲酰胺。过量的甲酰胺可作为反应溶剂,也可以加入反应溶剂,选自N,N-二甲酰胺、N,N-二乙酰胺、乙腈、二氯甲烷、1,2-二氯乙烷、三氟甲苯、氯苯、二氯苯。所述的吡啶类底物与溶剂的重量比为1:1~1000。In the above method, the carbonyl source and the nitrogen source are formamide. Excess formamide can be used as a reaction solvent, or a reaction solvent can be added, selected from N,N-diformamide, N,N-diacetamide, acetonitrile, dichloromethane, 1,2-dichloroethane, trifluoro Toluene, chlorobenzene, dichlorobenzene. The weight ratio of the pyridine substrate to the solvent is 1:1-1000.

上述方法中,所述的反应促进剂为水;所用水的量与有机相的体积比为0.001~1:1。最优选水的量与有机相的体积比为1:5。In the above method, the reaction accelerator is water; the volume ratio of the amount of water used to the organic phase is 0.001-1:1. The most preferred volume ratio of the amount of water to the organic phase is 1:5.

上述方法中,所述的吡啶类底物、催化剂、氧化剂、酸或碱的摩尔比为1~5:0.001~5:0.1~50:0.1~50。最优选的吡啶类底物、催化剂、氧化剂、酸或碱的摩尔比为1:0.2:3:2。In the above method, the molar ratio of the pyridine substrate, catalyst, oxidant, acid or base is 1-5:0.001-5:0.1-50:0.1-50. The most preferred molar ratio of pyridine substrate, catalyst, oxidizing agent, acid or base is 1:0.2:3:2.

上述方法中,反应温度为20~200℃,反应时间为1~48小时。In the above method, the reaction temperature is 20-200° C., and the reaction time is 1-48 hours.

借由上述技术方案,本发明的合成吡啶伯酰胺类化合物的方法至少具有下列优点:By means of the above-mentioned technical scheme, the method for synthesizing primary pyridine amides of the present invention has at least the following advantages:

本发明提供了一种直接利用甲酰胺为氨甲酰源,催化氧化吡啶类化合物的碳-氢键来合成吡啶伯酰胺类化合物的新方法。该方法具有催化剂廉价;反应原料稳定、来源广泛和廉价;反应无需配体选择性高;反应产生的废物少;氨甲酰源安全、易于存放和易于处理;底物的适用范围广的特点。所述的方法简单易行,在优化的反应条件之下,目标产品分离后收率高达98%,是一种直接、高效、廉价和环境友好的合成吡啶伯酰胺类化合物的方法。The invention provides a new method for synthesizing pyridine primary amide compounds by directly using formamide as a carboxamide source to catalyze and oxidize the carbon-hydrogen bond of pyridine compounds. The method has the characteristics of cheap catalyst, stable reaction raw material, wide source and low price, high selectivity without ligand, less waste generated by reaction, safe carboxamide source, easy storage and easy treatment, and wide application range of substrate. The method is simple and easy, and under optimized reaction conditions, the yield of the target product after separation is as high as 98%, and is a direct, efficient, cheap and environment-friendly method for synthesizing primary pyridine amides.

本发明方法制备的吡啶伯酰胺类化合物可用来制备具有独特的生物和药理活性化合物,在药物中间体、除草剂、活性药物分子、小分子探针和荧光材料等方面有着广泛的用途。The pyridine primary amide compound prepared by the method of the invention can be used to prepare unique biological and pharmacological active compounds, and has wide applications in pharmaceutical intermediates, herbicides, active drug molecules, small molecular probes, fluorescent materials and the like.

上述说明仅是本发明技术方案的概述,为了更进一步阐述本发明为达成预定发明目的所采取的技术手段及功效,对依据本发明提出的技术方案的具体实施方式、特征及其功效,详细说明如后。The above description is only an overview of the technical solution of the present invention. In order to further elaborate the technical means and effects adopted by the present invention to achieve the intended purpose of the invention, the specific implementation, features and effects of the technical solution proposed according to the present invention will be described in detail. As later.

具体实施方式detailed description

实施例1~18涉及吡啶伯酰胺类化合物的合成,实验结果列于表1:Embodiments 1-18 relate to the synthesis of pyridine primary amides, and the experimental results are listed in Table 1:

表1催化氧化法吡啶伯酰胺化合物的合成反应[a] Table 1 Catalytic Oxidation Synthetic Reaction of Pyridine Primary Amide [a]

[a]反应条件见实施例;[b]柱分离收率。[a] See the examples for the reaction conditions; [b] column separation yield.

实施例1Example 1

化合物1:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率94%。Compound 1: Add silver nitrate (0.1mmol), pyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide (2.0mL) and water to a 25mL reaction flask in an oxygen atmosphere (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 94%.

1HNMR(400MHz,DMSO):δ8.62(m,1H),8.11(s,1H),8.07-7.91(m,2H),7.64(s,1H),7.58(m,1H);13CNMR(100MHz,DMSO):δ166.5,150.7,148.9,138.1,126.9,122.4ppm. 1 HNMR (400MHz, DMSO): δ8.62 (m, 1H), 8.11 (s, 1H), 8.07-7.91 (m, 2H), 7.64 (s, 1H), 7.58 (m, 1H); 13 CNMR ( 100MHz, DMSO): δ166.5, 150.7, 148.9, 138.1, 126.9, 122.4ppm.

实施例2Example 2

化合物2:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),4-甲基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应3h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率89%。Compound 2: Under an oxygen atmosphere, silver nitrate (0.1mmol), 4-picoline (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 3h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 89%.

1HNMR(400MHz,DMSO):δ8.47(dd,J=4.9,0.5Hz,1H),8.08(s,1H),7.92-7.77(m,1H),7.60(s,1H),7.41(m,1H),2.39(s,3H);13CNMR(100MHz,DMSO):δ166.6,150.6,149.0,148.7,127.5,123.1,21.0ppm. 1 HNMR (400MHz, DMSO): δ8.47(dd, J=4.9, 0.5Hz, 1H), 8.08(s, 1H), 7.92-7.77(m, 1H), 7.60(s, 1H), 7.41(m ,1H),2.39(s,3H); 13 CNMR(100MHz,DMSO):δ166.6,150.6,149.0,148.7,127.5,123.1,21.0ppm.

实施例3Example 3

化合物3:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-乙基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率82%。Compound 3: Under an oxygen atmosphere, silver nitrate (0.1mmol), 2-ethylpyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 82%.

1HNMR(400MHz,DMSO):δ8.00(s,1H),7.91-7.80(m,2H),7.63(s,1H),7.45(dd,J=7.0,1.4Hz,1H),2.80(m,2H),1.26(m,3H);13CNMR(100MHz,DMSO):δ166.6,162.4,150.0,138.3,125.3,119.6,30.8,14.0ppm 1 HNMR (400MHz, DMSO): δ8.00(s, 1H), 7.91-7.80(m, 2H), 7.63(s, 1H), 7.45(dd, J=7.0, 1.4Hz, 1H), 2.80(m ,2H),1.26(m,3H); 13 CNMR(100MHz,DMSO):δ166.6,162.4,150.0,138.3,125.3,119.6,30.8,14.0ppm

实施例4Example 4

化合物4:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-戊基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应6h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率80%。Compound 4: Under an oxygen atmosphere, silver nitrate (0.1mmol), 2-pentylpyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 6h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 80%.

1HNMR(400MHz,DMSO):δ8.00(s,1H),7.97–7.82(m,2H),7.65(s,1H),7.47(dd,J=6.8,1.9,1H),2.95–2.71(m,2H),1.75(dt,J=14.8,7.6,2H),1.49–1.21(m,4H),0.90(t,J=7.0,3H);13CNMR(100MHz,DMSO):δ167.0,161.8,150.5,138.6,126.3,120.0,38.1,31.9,29.5,22.9,14.8ppm. 1 H NMR (400MHz, DMSO): δ8.00 (s, 1H), 7.97–7.82 (m, 2H), 7.65 (s, 1H), 7.47 (dd, J=6.8, 1.9, 1H), 2.95–2.71 ( m,2H),1.75(dt,J=14.8,7.6,2H),1.49–1.21(m,4H),0.90(t,J=7.0,3H); 13 CNMR(100MHz,DMSO):δ167.0,161.8, 150.5, 138.6, 126.3, 120.0, 38.1, 31.9, 29.5, 22.9, 14.8ppm.

实施例5Example 5

化合物5:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2,3-二甲基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率89%。Compound 5: Under an oxygen atmosphere, silver nitrate (0.1mmol), 2,3-lutidine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formazan Amide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 89%.

1HNMR(400MHz,DMSO):δ7.96(s,1H),7.76(d,J=7.6Hz,1H),7.67(d,J=7.6Hz,1H),7.55(s,1H),2.48(s,3H),2.30(s,3H);13CNMR(100MHz,DMSO):δ166.7,156.3,147.6,138.5,135.1,119.9,22.8,19.1ppm.IRνmax(KBr)/cm-1:611,683,744,870,1068,1127,1210,1260,1397,1584,1659,1691,3246,3383,3431.HRMS(ESI)calcd.forC8H10N2O[M+H]151.0871,found151.08607. 1 HNMR (400MHz, DMSO): δ7.96(s, 1H), 7.76(d, J=7.6Hz, 1H), 7.67(d, J=7.6Hz, 1H), 7.55(s, 1H), 2.48( s,3H),2.30(s,3H); 13 CNMR(100MHz,DMSO):δ166.7,156.3,147.6,138.5,135.1,119.9,22.8,19.1ppm.IRνmax(KBr)/cm -1 :611,683,744,870,1068, 1127, 1210, 1260, 1397, 1584, 1659, 1691, 3246, 3383, 3431. HRMS (ESI) calcd. for C 8 H 10 N 2 O [M+H] 151.0871, found 151.08607.

实施例6Example 6

化合物6:在氧气气氛下,25mL反应瓶中依次加入醋酸银(0.1mmol),2,4-二甲基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率90%。Compound 6: Under an oxygen atmosphere, silver acetate (0.1mmol), 2,4-lutidine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formazan Amide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 90%.

1HNMR(400MHz,DMSO):δ7.94(s,1H),7.67(d,J=0.8Hz,1H),7.56(s,1H),7.26(s,1H),2.48(s,3H),2.34(s,3H);13CNMR(100MHz,DMSO):δ166.7,157.3,150.0,149.0,126.9,120.3,24.2,20.9ppm. 1 HNMR (400MHz, DMSO): δ7.94(s, 1H), 7.67(d, J=0.8Hz, 1H), 7.56(s, 1H), 7.26(s, 1H), 2.48(s, 3H), 2.34(s,3H); 13 CNMR(100MHz,DMSO):δ166.7,157.3,150.0,149.0,126.9,120.3,24.2,20.9ppm.

实施例7Example 7

化合物7:在氧气气氛下,25mL反应瓶中依次加入溴化银(0.1mmol),3,5-二甲基吡啶(0.5mmol),乙酸钠(1.0mmol)、过氧化二异丙苯(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率89%。Compound 7: Under an oxygen atmosphere, silver bromide (0.1mmol), 3,5-lutidine (0.5mmol), sodium acetate (1.0mmol), dicumyl peroxide (1.5 mmol), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 89%.

1HNMR(400MHz,DMSO):δ8.25(s,1H),7.91(s,1H),7.52(s,1H),7.37(s,1H),2.50(m,3H),2.29(s,3H);13CNMR(100MHz,DMSO):δ168.8,146.9,146.5,140.9,135.7,133.5,20.0,18.0ppm. 1 HNMR(400MHz,DMSO):δ8.25(s,1H),7.91(s,1H),7.52(s,1H),7.37(s,1H),2.50(m,3H),2.29(s,3H ); 13 CNMR (100MHz, DMSO): δ168.8, 146.9, 146.5, 140.9, 135.7, 133.5, 20.0, 18.0ppm.

实施例8Example 8

化合物8:在氧气气氛下,25mL反应瓶中依次加入氯化亚铁(0.1mmol),2,3,5-三甲基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、乙酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率96%。Compound 8: Under an oxygen atmosphere, ferrous chloride (0.1mmol), 2,3,5-collidine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5 mmol), acetamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 96%.

1HNMR(400MHz,DMSO):δ7.93(s,1H),7.46(s,1H),7.38(s,1H),2.51(s,3H),2.45(s,3H),2.28(s,3H);13CNMR(100MHz,DMSO):δ169.3,153.8,146.1,142.0,134.6,131.7,22.7,19.9,19.2ppm.1HNMR(400MHz,DMSO):δ7.93(s, 1H ),7.46(s,1H),7.38(s,1H),2.51(s,3H),2.45(s,3H),2.28(s,3H ); 13 CNMR (100MHz, DMSO): δ169.3, 153.8, 146.1, 142.0, 134.6, 131.7, 22.7, 19.9, 19.2ppm.

实施例9Example 9

化合物9:在氧气气氛下,25mL反应瓶中依次加入铁粉(0.1mmol),4-甲氧基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率88%。Compound 9: Under an oxygen atmosphere, iron powder (0.1mmol), 4-methoxypyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide ( 2.0mL) and water (0.4mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 88%.

1HNMR(400MHz,DMSO):δ8.47-8.40(m,1H),8.09(s,1H),7.66(s,1H),7.55(d,J=2.4Hz,1H),7.14(dd,J=5.7,2.7Hz,1H),3.89(s,3H);13CNMR(100MHz,DMSO):δ166.9,166.3,152.8,150.3,112.9,108.1,56.1ppm. 1 H NMR (400MHz, DMSO): δ8.47-8.40 (m, 1H), 8.09 (s, 1H), 7.66 (s, 1H), 7.55 (d, J = 2.4Hz, 1H), 7.14 (dd, J =5.7,2.7Hz,1H),3.89(s,3H); 13 CNMR(100MHz,DMSO):δ166.9,166.3,152.8,150.3,112.9,108.1,56.1ppm.

实施例10Example 10

化合物10:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),3-甲氧基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率89%。Compound 10: Under an oxygen atmosphere, silver nitrate (0.1mmol), 3-methoxypyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide ( 2.0mL) and water (0.4mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 89%.

1HNMR(400MHz,DMSO):δ8.28(dd,J=2.9,0.6Hz,1H),7.99(dd,J=8.7,0.5Hz,1H),7.92(s,1H),7.51(dd,J=8.7,2.9Hz,1H),7.47(s,1H),3.88(s,3H).13CNMR(100MHz,DMSO)δ166.3,157.9,143.6,136.8,123.7,121.2,56.3ppm.IRνmax(KBr)/cm-1:651,1022,1279,1372,1423,1498,1586,1674,3204,3374.HRMS(ESI)calcd.forC7H8N2O2[M+H]153.0664,found153.06550. 1 H NMR (400MHz, DMSO): δ8.28 (dd, J = 2.9, 0.6Hz, 1H), 7.99 (dd, J = 8.7, 0.5Hz, 1H), 7.92 (s, 1H), 7.51 (dd, J =8.7,2.9Hz,1H),7.47(s,1H),3.88(s,3H). 13 CNMR(100MHz,DMSO)δ166.3,157.9,143.6,136.8,123.7,121.2,56.3ppm.IRν max (KBr) /cm -1 :651,1022,1279,1372,1423,1498,1586,1674,3204,3374.HRMS(ESI)calcd.for C 7 H 8 N 2 O 2 [M+H]153.0664,found153.06550.

实施例11Example 11

化合物11:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-甲氧基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率83%。1HNMR(400MHz,DMSO):δ8.01(s,1H),7.85(dd,J=8.3,7.3Hz,1H),7.65(s,1H),7.61(dd,J=7.3,0.8Hz,1H),6.99(dd,J=8.3,0.8Hz,1H),3.94(s,3H);13CNMR(100MHz,DMSO):δ166.3,163.0,148.4,140.6,115.6,114.2,53.9ppm.Compound 11: Under an oxygen atmosphere, silver nitrate (0.1mmol), 2-methoxypyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide ( 2.0mL) and water (0.4mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 83%. 1 HNMR (400MHz, DMSO): δ8.01(s, 1H), 7.85(dd, J=8.3, 7.3Hz, 1H), 7.65(s, 1H), 7.61(dd, J=7.3, 0.8Hz, 1H ),6.99(dd,J=8.3,0.8Hz,1H),3.94(s,3H); 13 CNMR(100MHz,DMSO):δ166.3,163.0,148.4,140.6,115.6,114.2,53.9ppm.

实施例12Example 12

化合物12:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-吡啶乙酮(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率86%。Compound 12: Under an oxygen atmosphere, silver nitrate (0.1mmol), 2-pyridineethanone (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 86%.

1HNMR(400MHz,DMSO):δ8.32(d,J=12.2,1H),8.29(d,J=7.7,1H),8.18(s,1H),8.15–8.11(m,1H),7.88(s,1H),2.79(s,3H);13CNMR(100MHz,DMSO):δ198.5,166.3,152.5,150.8,144.9,124.8,120.3,27.9ppm. 1 H NMR (400MHz, DMSO): δ8.32 (d, J = 12.2, 1H), 8.29 (d, J = 7.7, 1H), 8.18 (s, 1H), 8.15–8.11 (m, 1H), 7.88 ( s,1H),2.79(s,3H); 13 CNMR(100MHz,DMSO):δ198.5,166.3,152.5,150.8,144.9,124.8,120.3,27.9ppm.

实施例13Example 13

化合物13:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-乙氧基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率76%。Compound 13: Under an oxygen atmosphere, silver nitrate (0.1mmol), 2-ethoxypyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide ( 2.0mL) and water (0.4mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 76%.

1HNMR(400MHz,DMSO):δ7.97(s,1H),7.84(dd,J=8.2,7.3Hz,1H),7.63(s,1H),7.60(dd,J=7.3,0.7Hz,1H),6.97(dd,J=8.3,0.8Hz,1H),4.52-4.22(m,2H),1.34(m,3H);13CNMR(100MHz,DMSO):δ166.3,162.6,148.4,140.6,115.5,114.2,62.0,14.9ppm.IRνmax(KBr)/cm-1:606,699,779,790,868,1119,1244,1400,1576,1707,3174,3471.HRMS(ESI)calcd.forC8H10N2O2[M+H]167.0821,found167.08198. 1 HNMR (400MHz, DMSO): δ7.97(s, 1H), 7.84(dd, J=8.2, 7.3Hz, 1H), 7.63(s, 1H), 7.60(dd, J=7.3, 0.7Hz, 1H ),6.97(dd,J=8.3,0.8Hz,1H),4.52-4.22(m,2H),1.34(m,3H); 13 CNMR(100MHz,DMSO):δ166.3,162.6,148.4,140.6,115.5, 114.2,62.0,14.9ppm.IRν max (KBr)/cm -1 :606,699,779,790,868,1119,1244,1400,1576,1707,3174,3471.HRMS(ESI)calcd.for C 8 H 10 N 2 O 2 [M+ H]167.0821, found167.08198.

实施例14Example 14

化合物14:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-甲基-6-甲氧基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率87%。Compound 14: Under oxygen atmosphere, silver nitrate (0.1mmol), 2-methyl-6-methoxypyridine (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol) were successively added into a 25mL reaction flask ), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 87%.

1HNMR(400MHz,DMSO)δ8.10(s,1H),7.62(s,1H),7.25-7.19(m,1H),6.98(dd,J=1.1,0.6Hz,1H),3.85(s,3H),2.43(s,3H).13CNMR(100MHz,DMSO)δ166.7,164.1,157.0,145.5,114.3,105.9,53.8,24.4ppm.IRνmax(KBr)/cm-1679,816,888,1060,1209,1322,1391,1562,1610,1653,3182,3366.HRMS(ESI)calcd.forC8H10N2O2[M+H]167.0821,found167.08188. 1 HNMR (400MHz,DMSO)δ8.10(s,1H),7.62(s,1H),7.25-7.19(m,1H),6.98(dd,J=1.1,0.6Hz,1H),3.85(s, 3H),2.43(s,3H) .13 CNMR(100MHz,DMSO)δ166.7,164.1,157.0,145.5,114.3,105.9,53.8,24.4ppm.IRν max (KBr)/cm -1 679,816,888,1060,1209,1322 , 1391, 1562, 1610, 1653, 3182, 3366. HRMS (ESI) calcd. for C 8 H 10 N 2 O 2 [M+H] 167.0821, found 167.08188.

实施例15Example 15

化合物15:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),4-吡啶乙酮(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率90%。Compound 15: Under an oxygen atmosphere, silver nitrate (0.1mmol), 4-pyridineethanone (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 90%.

1HNMR(400MHz,DMSO):δ8.89(dd,J=5.0,0.8,1H),8.42(dd,J=1.7,0.8,1H),8.26(s,1H),8.04(dd,J=5.0,1.7,1H),7.83(s,1H),2.72(s,3H);13CNMR(100MHz,DMSO)δ198.5,166.3,152.5,150.8,144.9,124.8,120.3,27.9ppm. 1 HNMR (400MHz, DMSO): δ8.89 (dd, J = 5.0, 0.8, 1H), 8.42 (dd, J = 1.7, 0.8, 1H), 8.26 (s, 1H), 8.04 (dd, J = 5.0 ,1.7,1H),7.83(s,1H),2.72(s,3H); 13 CNMR(100MHz,DMSO)δ198.5,166.3,152.5,150.8,144.9,124.8,120.3,27.9ppm.

实施例16Example 16

化合物16:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),2-吡啶甲酸乙酯(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应6h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率75%。Compound 16: Under an oxygen atmosphere, silver nitrate (0.1mmol), ethyl 2-pyridinecarboxylate (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide ( 2.0mL) and water (0.4mL). The mixture was reacted at 80°C for 6h. After cooling to room temperature, the solvent was evaporated under reduced pressure and separated by column chromatography to obtain the product with a yield of 75%.

1HNMR(400MHz,DMSO):δ8.31–8.18(m,3H),7.93(s,1H),7.88(s,1H),4.43(q,J=7.1,2H),1.40(t,J=7.1,3H);13CNMR(100MHz,DMSO):δ166.1,165.0,151.4,147.6,140.2,128.0,126.0,62.4,15.0ppm. 1 HNMR (400MHz, DMSO): δ8.31–8.18(m, 3H), 7.93(s, 1H), 7.88(s, 1H), 4.43(q, J=7.1, 2H), 1.40(t, J= 7.1,3H); 13 CNMR(100MHz,DMSO):δ166.1,165.0,151.4,147.6,140.2,128.0,126.0,62.4,15.0ppm.

实施例17Example 17

化合物17:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),4-吡啶甲酸甲酯(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率95%。Compound 17: Under an oxygen atmosphere, silver nitrate (0.1mmol), methyl 4-pyridinecarboxylate (0.5mmol), sodium acetate (1.0mmol), potassium persulfate (1.5mmol), formamide ( 2.0mL) and water (0.4mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 95%.

1HNMR(400MHz,DMSO):δ8.85(d,J=4.9Hz,1H),8.42(d,J=0.8Hz,1H),8.24(s,1H),8.02(dd,J=4.9,1.7Hz,1H),7.81(s,1H),3.93(s,3H);13CNMR(100MHz,DMSO):δ165.7,165.2,152.0,150.4,138.8,125.5,121.1,53.4ppm. 1 HNMR (400MHz, DMSO): δ8.85 (d, J = 4.9Hz, 1H), 8.42 (d, J = 0.8Hz, 1H), 8.24 (s, 1H), 8.02 (dd, J = 4.9, 1.7 Hz,1H),7.81(s,1H),3.93(s,3H); 13 CNMR(100MHz,DMSO):δ165.7,165.2,152.0,150.4,138.8,125.5,121.1,53.4ppm.

实施例18Example 18

化合物18:在氧气气氛下,25mL反应瓶中依次加入硝酸银(0.1mmol),3-甲基-2-苯基吡啶(0.5mmol),乙酸钠(1.0mmol)、过硫酸钾(1.5mmol)、甲酰胺(2.0mL)和水(0.4mL)。混合物在80℃下反应4h。冷却到室温,减压蒸除溶剂后柱层析分离得到产物,产率51%。Compound 18: Add silver nitrate (0.1mmol), 3-methyl-2-phenylpyridine (0.5mmol), sodium acetate (1.0mmol) and potassium persulfate (1.5mmol) in sequence to a 25mL reaction flask under an oxygen atmosphere , formamide (2.0 mL) and water (0.4 mL). The mixture was reacted at 80°C for 4h. After cooling to room temperature, the solvent was distilled off under reduced pressure and separated by column chromatography to obtain the product with a yield of 51%.

1HNMR(400MHz,DMSO):δ7.95(s,1H),7.94-7.88(m,2H),7.68-7.62(m,2H),7.60(s,1H),7.53-7.41(m,3H),2.39(s,3H);13CNMR(100MHz,DMSO):δ166.7,157.0,148.3,140.5,139.9,134.3,129.7,128.7,128.6,120.8,20.3ppm.IRνmax(KBr)/cm-11089,1262,1308,1385,1463,1594,1666,2928,2982,3324,3385,3446.HRMS(ESI)calcd.forC13H12N2O[M+H]213.1028,found213.10201. 1 HNMR(400MHz,DMSO):δ7.95(s,1H),7.94-7.88(m,2H),7.68-7.62(m,2H),7.60(s,1H),7.53-7.41(m,3H) ,2.39(s,3H); 13 CNMR(100MHz,DMSO):δ166.7,157.0,148.3,140.5,139.9,134.3,129.7,128.7,128.6,120.8,20.3ppm.IRν max (KBr)/cm -1 1089, 1262, 1308, 1385, 1463, 1594, 1666, 2928, 2982, 3324, 3385, 3446. HRMS (ESI) calcd. for C 13 H 12 N 2 O [M+H] 213.1028, found 213.10201.

Claims (10)

1. the method for a Direct Catalytic Oxidation method pyridine synthesis primary amide compound; it is characterized in that; under air or oxygen atmosphere; add oxidant, accelerator water and acid or alkali; with Methanamide for carbamylating agent; under silver catalyst and/or iron catalyst effect, the carbon-hydrogen link of catalytic oxidation pyridine or derivatives thereof directly prepares pyridine primary amide compound, and reaction expression is expressed as follows:
R in formula1~R4Arbitrarily selected from hydrogen, the alkyl of C1~C12, alkenyl or alkynyl, the alkoxyl of C1~C12, the fluorine of C1~C12 replaces alkyl; the cycloalkyl of C3~C12, aryl, aryloxy group or aryl amine, heteroaryl, heteroaryloxy or assorted aryl amine, the amino that C1~C12 alkyl replaces; C1~C12 sulfydryl, fluorine, hydroxyl, C1~C12 alkyl-carbonyl; C1~C12 alkoxy carbonyl, aryl carbonyl, carboxyl; C1~C12 alkanoyloxy, cyano group, C1~C12 alkane sulfonyl; sulfonic group, sulfonate group, phosphate-based or nitro.
2. synthetic method according to claim 1, it is characterised in that described heteroaryl is the heteroaryl of five~fourteen-ring containing one or more N, O or S.
3. synthetic method according to claim 1, it is characterised in that described acid is trifluoro formic acid, trifluoroacetic acid, formic acid, acetic acid, pivalic acid, 2-nitrobenzoic acid, p-methyl benzenesulfonic acid or trifluoromethanesulfonic acid.
4. synthetic method according to claim 1, it is characterised in that described alkali is inorganic base or organic base; Described inorganic base is potassium phosphate, sodium phosphate, sodium fluoride, potassium fluoride, cesium fluoride, lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, Feldalat NM, sodium acetate, potassium acetate, cesium acetate, Sodium ethylate, tert-butyl alcohol lithium, Lithium hydrate, sodium propionate, potassium propionate, sodium butyrate, potassium butyrate, sodium benzoate, pivalic acid sodium, pivalic acid potassium; Described organic base be tetrabutyl ammonium fluoride, triethylamine, diisopropylethylamine, tri-n-butylamine, 1,4-diazabicylo [2.2.2] octane, 1,8-diazabicylo [5.4.0] 11 carbon-7-alkene or 1,5-diazabicylo [4.3.0]-5-in ninth of the ten Heavenly Stems alkene.
5. synthetic method according to claim 1, it is characterized in that, described silver catalyst is silver nitrate, silver acetate, silver trifluoroacetate, silver sulfate, silver fluoborate, actol, silver phosphate, Argentous sulfide., Argentous fluoride, silver chloride, silver iodide, Silver monobromide, Disilver carbonate, p-methyl benzenesulfonic acid silver, silver trifluoromethanesulfonate, silver benzoate or methanesulfonic acid silver.
6. synthetic method according to claim 1, it is characterized in that, described iron catalyst is iron powder, trifluoromethanesulfonic acid ferrous iron, trifluoromethanesulfonic acid ferrum, ferrous chloride, ferric acetyl acetonade, ferroferricyanide, ferric ferricyanide, Ferrous acetate, ferrous sulfate, Ferrous ammonium sulfate, Ferrox., ferric oxalate, ferrous fluoride, ferric flouride, ferrous bromide, ferric bromide, iron iodide, ferric chloride, ferrum oxide or ferroso-ferric oxide.
7. synthetic method according to claim 1, it is characterised in that described oxidant is Ammonium persulfate., potassium peroxydisulfate, sodium peroxydisulfate, peroxosulphuric hydrogen potassium complex salt, di-tert-butyl peroxide or cumyl peroxide.
8. synthetic method according to claim 1, it is characterised in that the amount of described accelerator water and the volume ratio of organic facies are 0.001~1:1.
9. synthetic method according to claim 1, it is characterised in that the mol ratio of described pyridine or derivatives thereof, catalyst, oxidant, acid or alkali is 1~5:0.001~5:0.1~50:0.1~50.
10. synthetic method according to claim 1, it is characterised in that in described method, reaction temperature is 20~200 DEG C, and the response time is 1~48 hour.
CN201610131789.3A 2016-03-08 2016-03-08 Method for synthesizing pyridine primary amides by direct catalytic oxidation process Pending CN105669542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610131789.3A CN105669542A (en) 2016-03-08 2016-03-08 Method for synthesizing pyridine primary amides by direct catalytic oxidation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610131789.3A CN105669542A (en) 2016-03-08 2016-03-08 Method for synthesizing pyridine primary amides by direct catalytic oxidation process

Publications (1)

Publication Number Publication Date
CN105669542A true CN105669542A (en) 2016-06-15

Family

ID=56307270

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610131789.3A Pending CN105669542A (en) 2016-03-08 2016-03-08 Method for synthesizing pyridine primary amides by direct catalytic oxidation process

Country Status (1)

Country Link
CN (1) CN105669542A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112239423A (en) * 2020-02-17 2021-01-19 浙江大学 Synthetic method of alpha-arylated amide compound
US11168068B2 (en) 2016-07-18 2021-11-09 Janssen Pharmaceutica Nv Tau PET imaging ligands

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245803A (en) * 1998-08-10 2000-03-01 弗·哈夫曼-拉罗切有限公司 Method for preparing substituted pyridines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245803A (en) * 1998-08-10 2000-03-01 弗·哈夫曼-拉罗切有限公司 Method for preparing substituted pyridines

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DENNIS U. NIELSEN,等: "Palladium-Catalyzed Approach to Primary Amides Using Nongaseous Precursors", 《ORGANIC LETTERS》 *
HARAL D BERNARD,等: "Technical Scale Synthesis of a New and Highly Potent Thrombin Inhibitor", 《SYNTHESIS》 *
IVAR MARTIN,等: "An alternative synthesis of the NMDA antagonist CGS 19755 via free radical carbamoylation of ethyl isonicotinate", 《ACTA CHEMICA SCANDINAVICA》 *
MOHAMMAD A,等: "Hydroxymethylation and Carbamoylation of Di-And Tetramethylpyridines Using Radical Substitution (Minisci) Reactions", 《SYNTHETIC COMMUNICATIONS》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11168068B2 (en) 2016-07-18 2021-11-09 Janssen Pharmaceutica Nv Tau PET imaging ligands
US12006302B2 (en) 2016-07-18 2024-06-11 Janssen Pharmaceutica Nv Tau PET imaging ligands
CN112239423A (en) * 2020-02-17 2021-01-19 浙江大学 Synthetic method of alpha-arylated amide compound
CN112239423B (en) * 2020-02-17 2022-03-04 浙江大学 A kind of synthetic method of α-arylation amide compound

Similar Documents

Publication Publication Date Title
Cao et al. Manganese (iii)-mediated direct C sp2–H radical trifluoromethylation of coumarins with sodium trifluoromethanesulfinate
Brennführer et al. Palladium‐catalyzed carbonylation reactions of aryl halides and related compounds
Guo et al. Silver tungstate: a single-component bifunctional catalyst for carboxylation of terminal alkynes with CO 2 in ambient conditions
CN105061124B (en) Diarylmethane compound preparation method
CN108558635B (en) Preparation method of 3-arylpropynoic acids and 3-arylpropynoic acid ester compounds
CN106831283A (en) A kind of method of the iodo alkynes of high selectivity 1
CN105669542A (en) Method for synthesizing pyridine primary amides by direct catalytic oxidation process
CN105131044B (en) Three core N-heterocyclic carbine palladium compounds and synthetic method and application
CN114539097B (en) A kind of multi-substituted alkenyl cyanide and its synthetic method
Boualy et al. Copper (II) catalyzed allylic amination of terpenic chlorides in water
CN108440483A (en) One kind 3,4-, bis- hydroxys -2(7H)-one and preparation method
CN102010282A (en) Method for preparing diaryl disulfide and diaryl diselenide under catalysis of aqueous phase
CN116162027A (en) A method for the synthesis of α,β-unsaturated ketones by iron-catalyzed carbonylation three-component coupling reaction
CN102731386B (en) Preparation method of para-diimide derivative
CN109438299B (en) Method for synthesizing benzenesulfonyl enamine compound from benzenesulfonyl hydrazide derivative and triethylamine under metal-free catalysis
CN114605306A (en) Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof
CN109232333B (en) Method for metal-free catalytic synthesis of benzenesulfonyl enamine compounds by benzene sulfinic acid sodium salt and triethylamine
CN107459485B (en) A kind of new method of the imino-diacetic benzylidene derivative aminating reaction of nickel catalysis
CN115677539B (en) A cobalt-catalyzed method for highly selective monoalkenylation of urea-directed aromatics under mild conditions
CN103044421B (en) Palladium-catalyzed preparation method of benzimidazo-isoquinolin
CN105130898B (en) One kind is together with difluoro polycyclic compound and preparation method thereof
CN104478799A (en) Preparation method of 1,4-diallyl isoquinoline
CN105348288B (en) A kind of synthetic method of 5,10-indoline [3,2-b] indole compound
CN110078661A (en) A kind of preparation method of 3- alkenyl-bipy 2,2' bipyridyl -6- carboxamides derivatives
CN111533649B (en) Synthesis method of acid compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160615

WD01 Invention patent application deemed withdrawn after publication